NIH Schedules Closed Grant Review Meetings
Published Date: 6/18/2026
Notice
Summary
The Center for Scientific Review is holding several closed virtual meetings in July 2026 to review and decide on important research grant applications. These meetings protect private info and trade secrets while helping decide funding for health research projects. Scientists and researchers applying for grants should note these dates as they impact which projects get money.
Analyzed Economic Effects
2 provisions identified: 2 benefits, 0 costs, 0 mixed.
NIH Grant Panels Meet Virtually in July
The NIH Center for Scientific Review will hold several closed virtual meetings on July 14, July 15, and July 16, 2026 to review and evaluate grant applications for multiple panels (for example: High Priority HIV and Substance Use Research; Pathobiology of Kidney Disease; Neurobiology; Nutrition, Diet, Obesity and Diabetes; and others). These meetings are where decisions are made about which research projects receive NIH funding.
Meetings Closed to Protect IP and Privacy
These NIH review meetings are closed to the public under sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., and pursuant to section 1009 of the Federal Advisory Committee Act, to protect confidential trade secrets, patentable material, and personal information in grant applications. If you apply for NIH funding, your trade secrets and personal data are formally protected during these reviews.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-20771, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in early November 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, affecting researchers seeking funding. No direct money changes are announced, but these reviews decide who gets research grants.
2026-20705, Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Antibody Specifically Binding to Severe Fever With Thrombocytopenia Syndrome Virus Antigen and Use Thereof
The National Institute of Allergy and Infectious Diseases plans to give Korea National Institute of Health an exclusive license to develop and sell a special antibody that targets a dangerous virus causing severe fever and low platelets. This deal helps speed up turning the invention into real-world treatments. Comments or license requests must be sent by October 26, 2026.
2026-20424, National Cancer Institute; Notice of Meeting
The President's Cancer Panel is holding a free virtual meeting on October 15, 2026, to talk about how GLP-1 medications can help lower cancer risks linked to obesity. Anyone interested can join online or send in comments beforehand. This meeting is a great chance for patients, doctors, and researchers to learn about new ways to fight cancer and improve health.
2026-20365, Center For Scientific Review; Notice of Closed Meetings
The NIH's Center for Scientific Review is holding several closed virtual meetings on October 29-30, 2026, to review and evaluate grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists applying for grants in areas like biochemistry, software engineering, and mental health will be affected, with no direct money changes announced but important decisions coming soon.
2026-20151, Notice of NIH Tribal Consultations and Listening Session
The NIH is inviting Tribal leaders and members to join two important meetings and a listening session during the National Congress of American Indians Annual Convention in October 2026. They’ll talk about new health research projects, renewing support for Tribal health centers, and shaping a new Tribal Data Sovereignty Policy. Tribes can also send their thoughts by November 20, 2026, helping shape future health programs and policies.
2026-19719, Center for Scientific Review; Amended Notice of Meeting
The NIH’s Center for Scientific Review is shortening a key meeting from two days to just one day on October 13, 2026, keeping the same 9 a.m. to 6 p.m. hours. This change affects members of the Surgical Sciences and Bioengineering review group and means less time in the room but no public access. No money changes or delays are expected—just a quicker, tighter meeting!
Previous / Next Documents
Previous: 2026-12243, Notice of Request for Revision to and Extension of Approval of an Information Collection; African Swine Fever; Importation of Live Dogs for Resale From Regions Where ASF Exists or Is Reasonably Believed To Exist
The USDA is updating and extending rules about importing live dogs for resale from places where African Swine Fever (ASF) is known or suspected. This affects dog importers who must provide updated info to help keep ASF out of the U.S. You’ve got until August 17, 2026, to share your thoughts, and these changes aim to keep things safe without adding big costs.
Next: 2026-12245, Authorization of Emergency Use for Two Animal Drugs for the Prevention and Treatment of New World Screwworm; Availability
The FDA just gave the green light for two new animal drugs to fight the nasty New World screwworm, a bug that harms cattle, horses, pigs, and even exotic animals. These emergency approvals started in April 2026 to help protect U.S. livestock and wildlife quickly. Farmers, vets, and animal lovers can now use these treatments to stop infestations and keep animals safe without delay.